Real-world study checks how breast cancer patients cope with hormone-blocking shots
NCT ID NCT05122377
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study followed 562 premenopausal women with hormone receptor-positive breast cancer after surgery. Researchers wanted to understand their quality of life and how well they stuck to treatment with GnRHa, a drug that temporarily stops the ovaries from making estrogen. The goal was to gather real-world feedback, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
Conditions
Explore the condition pages connected to this study.